3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence-based missed-dose protocol for Repatha (evolocumab), including timing rules for biweekly and monthly schedules, pharmacokinetic rationale, and clinical guidance from the FDA label.
A guide to evolocumab (Repatha) hair and skin effects, covering FOURIER trial data, PCSK9 biology, real-world reports, and clinical management steps.
A clinician-focused guide to the evolocumab (Repatha) pre-surgery hold window, covering pharmacokinetics, guideline recommendations, FOURIER trial data, and practical perioperative protocols for patients on PCSK9 inhibitor therapy.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.